Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...
Financial Post1 个月
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support ...
(“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, today featured a ...